ABSTRACT
It is long known that facial configurations play a critical role when inferring mental and emotional states from others. Nevertheless, there is still a scientific debate on how we infer emotions from facial configurations. The theory of constructed emotion (TCE) suggests that we may infer different emotions from the same facial configuration, depending on the context (e.g. provided by visual and lexical cues) in which they are perceived. For instance, a recent study found that participants were more accurate in inferring mental and emotional states across three different datasets (i.e. RMET, static and dynamic emojis) when words were provided (i.e. forced-choice task), compared to when they were not (i.e. free-labelling task), suggesting that words serve as contexts that modulate the inference from facial configurations. The goal of the current within-subject study was to replicate and extend these findings by adding a fourth dataset (KDEF-dyn), consisting of morphed human faces (to increase the ecological validity). Replicating previous findings, we observed that words increased accuracy across the three (previously used) datasets, an effect that was also observed for the facial morphed stimuli. Our findings are in line with the TCE, providing support for the importance of contextual verbal cues in emotion perception.
Subject(s)
Emotions , Facial Expression , HumansABSTRACT
AIM: Peroxisome proliferator activated receptors (PPARs) are nuclear receptors involved in glucose and lipid metabolism. Three isoforms of PPARs have been identified with different tissue distribution and biological functions. Although the pharmacology of each receptor is well studied, the physiological effect of simultaneous activation of PPARalpha, gamma and delta is only starting to emerge. We sought to determine the biological effects of a novel PPAR pan activator and elucidate the physiological mechanisms involved. METHODS: Ob/ob, diet-induced obese (DIO) or PPARalpha knockout mice were administered a novel agonist that activates all PPARs to various degrees to determine the effect on body weight, body composition, food intake and energy expenditure. In addition, serum parameters including glucose, insulin, triglycerides and ketone bodies as well as tissue acylcarnitine were evaluated. The effect of the novel agonist on liver and skeletal muscle histopathology was also studied. RESULTS: We report that simultaneous activation of all PPARs resulted in substantial weight loss in ob/ob and DIO mice. Consistent with known PPAR pharmacology, we observed that agonist treatment increased lipid oxidation, although appetite suppression was mainly responsible for the weight loss. Agonist-induced weight loss was completely absent in PPARalpha knockout mice suggesting that PPARalpha pharmacology was the major contributor to weight regulation in mice. CONCLUSIONS: Our work provides evidence that simultaneous activation of PPARalpha, gamma and delta decreases body weight by regulating appetite. These effects of the pan agonist were completely absent in PPARalpha knockout mice, suggesting that PPARalpha pharmacology was the major contributor to weight loss.
Subject(s)
Appetite Depressants/pharmacology , Obesity/drug therapy , PPAR alpha/agonists , PPAR delta/agonists , PPAR gamma/agonists , Weight Loss/physiology , Animals , Appetite Regulation/physiology , Energy Metabolism/physiology , Insulin Resistance/physiology , Lipid Peroxidation/physiology , Male , Mice , Mice, Inbred C57BL , Mice, Knockout , Obesity/physiopathology , PPAR alpha/genetics , PPAR gamma/genetics , Rosiglitazone , Thiazoles/pharmacology , Thiazolidinediones/pharmacologyABSTRACT
OBJECTIVE: To address the potential contribution of subcortical brain regions in the functional reorganization of the motor system in patients with sporadic ALS (sALS) and to investigate whether functional changes in brain activity are different in sALS patients with predominant upper motor neuron (UMN) or lower motor neuron (LMN) dysfunction. METHODS: We studied 16 patients with sALS and 13 healthy controls, using BOLD-fMRI, while they performed a simple visually paced motor task. Seven patients had definite clinical UMN signs while nine patients had prevalent clinical and electrophysiological LMN involvement. fMRI data were analyzed with Brain Voyager QX. RESULTS: Task-related functional changes were identified in motor cortical regions in both patients and healthy controls. Direct group comparisons revealed relatively decreased BOLD fMRI responses in left sensorimotor cortex, lateral premotor area, supplementary motor area and right posterior parietal cortex (p < 0.05 corrected) and relatively increased responses in the left anterior putamen (p < 0.001 uncorrected) in sALS patients. Additional analyses between the two patients subgroups demonstrated significant BOLD fMRI response differences in the anterior cingulate cortex and right caudate nucleus (p < 0.001 uncorrected) with more robust activation of these areas in patients with greater UMN burden. Importantly, there were no significant differences in performance of the motor task between sALS patients and controls as well as between sALS patient subgroups. CONCLUSIONS: Our data demonstrate a different BOLD fMRI pattern between our sALS patients and healthy controls even during simple motor behavior. Furthermore, patients with sALS and greater UMN involvement show a different reorganization of the motor system compared to sALS patients with greater LMN dysfunction.